Live
Endpoints NewsFlagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experienceIlluminaSwiss National Bank Reduces Illumina Holdings - National TodayBioPharma DiveNew FDA guidance could elevate pharma’s biosimilar market10x Genomics Blog3 Healthcare Stocks to Avoid in 2026: Analysis of Underperformers - News and Statistics - IndexBox - Market Intelligence PlatformAgilentMagnetar Financial LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat10x Genomics Blog3 Healthcare Stocks We’re Skeptical Of - Yahoo! Finance CanadaAgilentPreventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System - bioprocessonline.comEndpoints NewsGrail names new CEO as Bob Ragusa retiresFierceBiotechStop Asking for an AI strategy: 3 questions clinical leaders should ask insteadThermo FisherInsider Sell: Michael Shafer Sells Shares of Thermo Fisher Scien - GuruFocusCellHuman-specific features of the cerebellum and ZP2-regulated synapse developmentCellCell-type-specific transposon demethylation and TAD remodeling in aging mouse brain
BioPharma Dive Mar 13, 2026

New FDA guidance could elevate pharma’s biosimilar market

New FDA guidance could elevate pharma’s biosimilar market

Original
Body unavailable. Use the original source.

Directory

59 All